Managing Chemotherapy-Induced Nausea and Vomiting (CINV) to Improve Patient Care

SEPTEMBER 27, 2017
Sally Yowell Barbour, Pharma, BCOP, CPP, FHOPA; and Patrick Medina, PharmD
This activity is supported by educational grants from Eisai Inc. and Tesaro, Inc.

Managing Chemotherapy-Induced Nausea and Vomiting (CINV) to Improve Patient Care

Sally Yowell Barbour, PharmD, BCOP, CPP, FHOPA
Director of Oncology Pharmacy Programs
Duke University Medical Center Durham, North Carolina

Patrick Medina, PharmD
Professor of Medicine Stephenson Cancer Center University of Oklahoma Oklahoma City, Oklahoma

Medical Writers
Thomas J. Cook, PhD, RPh
Freelance Medical Writer Stewartsville, New Jersey

Joanne Faysal
Medical Writer
South Palm Beach, Florida

Educational Objective
At the completion of this activity, the participant will be able to:
  1. Discuss pharmacologic treatment options to manage chemotherapy-induced nausea and vomiting (CINV)
  2. Identify appropriate monitoring parameters based on chemotherapy and CINV regimen
  3. Apply safety and efficacy data when evaluating CINV agents
Target Audience: Pharmacists and pharmacy directors ACTIVITY TYPE: Application
Release Date: September 12, 2017
Expiration Date: September 12, 2018
Estimated Time to Complete Activity: 2.0 hours
Fee: This lesson is offered for free at

Pharmacy Times Continuing EducationTM is accredited by the Accreditation Council for Pharmacy Education (ACPE) as a provider of continuing pharmacy education. This activity is approved for 2.0 contact hours (0.20 CEUs) under the ACPE universal activity number 0290-0000-17-143-H01-P. The activity is available for CE credit through Sept. 12, 2018.